Full-Time

Cell Therapy Process Engineer I

Sana Biotechnology

Sana Biotechnology

201-500 employees

Engineers cells as medicines for untreatable diseases

Biotechnology

$100,000 - $120,000

Employee Stock Purchase Plan

Mid

Seattle, WA, USA

Required Skills
Python
R
Requirements
  • Bachelor’s in Chemical, Biological or Biomedical Engineering plus 4 yrs or MSc plus 1-2 yrs or equivalent combination of education and work experience
  • 2 years of experience in biologics, viral vector, or cell therapy manufacturing
  • Detail-oriented with good problem-solving, technical writing and verbal communication skills
  • Ability to effectively work in multidisciplinary teams, meet deadlines, and prioritize multiple projects
  • Aptitude for working in a self-driven, performance/results-oriented, fast-paced matrix environment
  • Experience with cell therapy manufacturing processes and equipment including T cell isolation, lentiviral transduction, gene editing, expansion in bioreactors, cell harvest, and cryopreservation
  • Well versed with cGMP requirements and working in a regulated environment
  • Prior experience supporting tech transfers to external partners
  • Working knowledge of statistical Design of Experiments (DoE)
  • Knowledge of R, Python, JMP, Spotfire
Responsibilities
  • Serve as technical person-in-plant at the contract manufacturing site providing on the floor technical support to drive manufacturing excellence
  • Collect and analyze manufacturing data to identify areas for improvement
  • Support investigations, participate in root cause analyses, and recommend appropriate corrective actions
  • Participate in technology transfers and support implementation of operational improvements for manufacturing processes
  • Support training of manufacturing personnel to implement new processes and procedures
  • Draft technical documents including master batch records and components of technology transfer packages
  • Function as a manufacturing subject matter expert within the MSAT organization

Sana Biotechnology, Inc. stands out as a leading company in the cell and gene therapy industry, with a unique focus on using engineered cells as medicines to treat diseases with poor outcomes or that are currently untreatable. Their competitive edge lies in their advanced delivery technologies, their ability to differentiate pluripotent stem cells into immune-cloaked functional cells, and their commitment to scalable manufacturing solutions. The company's culture is deeply rooted in impacting patients' lives, as evidenced by their ongoing development of diverse drug candidates aimed at broadening treatment possibilities.

Company Stage

IPO

Total Funding

$865M

Headquarters

Seattle, Washington

Founded

2018

Growth & Insights
Headcount

6 month growth

-13%

1 year growth

-18%

2 year growth

-9%